Company: PCOR
Filing Date: 2025-09-22
Form Type: 8-K
Source: 0001193125-25-211312
Chunk: 1

Company: PROCORE TECHNOLOGIES, INC.
Filing Date: 2025-09-22
Form: 8-K
Item: Item 5.02
Chunk 1
---
 Inc., an enterprise software company. From 2004 to 2006, he served as Executive Vice President and Chief Technology Officer at Symantec. In 2000, he co-foundedReefEdge Networks, a wireless local area network system provider, and served as its Chief Executive Officer until 2004. From 1991 to 2000, Dr. Gopal held a number of positions at International Business Machines Corporation, a technology company, including at IBM Research and IBM’s software group. He began his career in 1984 at Bell Communications Research, a telecommunications company. Dr. Gopal has served on the board of directors of Synopsys since July 2025, and on the board of directors of Fiserv, Inc., a financial technology and payment solutions company, since March 2024. He previously served on the board of directors of Ansys from July 2011 to July 2025 and Citrix Systems, Inc., an enterprise software company, from September 2017 to October 2021. Dr. Gopal has also served as a member of the Board of Trustees of Carnegie Mellon University since 2022. Dr. Gopal holds a bachelor of technology degree in mechanical engineering from the Indian Institute of Technology Bombay and a doctorate in computer science from Cornell University. Dr. Gopal was selected to serve on the Board because of his extensive experience in the technology and software industries and his service as an executive and a director of many publicly-traded companies.

Pursuant to Dr. Gopal’s offer letter dated September 22, 2025 (the “ CEO Offer Letter”), a copy of which is attached as Exhibit 10.1 to this Current Report on Form8-K, and incorporated herein by reference, Dr. Gopal will earn an annual base salary of $750,000 beginning on the Initial Start Date. He will also be eligible to earn an annual target bonus equal to 150% of his annual base salary (the “ Target Bonus”) under the Company’s 2026 executive bonus program, with an opportunity to earn up to 200% of the Target Bonus based on Company performance. Dr. Gopal will also receive a one-time sign-onbonus of $320,000, and will be eligible to be reimbursed up to $125,000 for reasonable attorneys’ fees he incurred in connection with the consideration and negotiation of his employment with the Company.

Effective as of the Initial Start Date, Dr. Gopal was granted a restricted stock unit (“ RSU”)